rs146205352
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1
The NM_181882.3(PRX):āc.3838G>Cā(p.Glu1280Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000238 in 1,599,954 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_181882.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRX | NM_181882.3 | c.3838G>C | p.Glu1280Gln | missense_variant | Exon 7 of 7 | ENST00000324001.8 | NP_870998.2 | |
PRX | NM_001411127.1 | c.4123G>C | p.Glu1375Gln | missense_variant | Exon 7 of 7 | NP_001398056.1 | ||
PRX | XM_017027047.2 | c.3736G>C | p.Glu1246Gln | missense_variant | Exon 4 of 4 | XP_016882536.1 | ||
PRX | NM_020956.2 | c.*4043G>C | 3_prime_UTR_variant | Exon 6 of 6 | NP_066007.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00127 AC: 193AN: 152168Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000311 AC: 69AN: 221994Hom.: 0 AF XY: 0.000215 AC XY: 26AN XY: 121198
GnomAD4 exome AF: 0.000129 AC: 187AN: 1447668Hom.: 0 Cov.: 33 AF XY: 0.000108 AC XY: 78AN XY: 719500
GnomAD4 genome AF: 0.00127 AC: 193AN: 152286Hom.: 0 Cov.: 32 AF XY: 0.00120 AC XY: 89AN XY: 74466
ClinVar
Submissions by phenotype
not provided Uncertain:1
The PRX c.3838G>C; p.Glu1280Gln variant (rs146205352), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 543486). This variant is listed in the Genome Aggregation Database (gnomAD) with an overall population frequency of 0.45 percent in the African population (identified on 100 out of 22,178 chromosomes). The glutamic acid at position 1280 is highly conserved and computational analyses of the effects of the p.Glu1280Gln variant on protein structure and function is conflicting (SIFT: tolerated, PolyPhen-2: probably damaging). In addition computational analyses (Alamut v.2.11) predict that this variant may impact splicing by creating a novel cryptic acceptor splice site/weakening the nearby canonical splice site. Overall, there is not enough evidence to classify the p.Glu1280Gln variant with certainty. -
PRX-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Charcot-Marie-Tooth disease type 4 Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at